Haha just found the old PolyMedix fact sheet

http://files.shareholder.com/downloads/ABEA-4..._2012_.pdf
-
30063) Antibiotic Fact Sheet
www.polymedix.com
February 2013
Defensin
-
Mimetic Attributes
Unique Mechanism of Action Fundamentally
Different from ALL Current Systemic Antibiotics

Serial passage resistance studies are used to demonstrate the
potential for bacterial resistance to develop to antibiotics. The
graph shows brilacidin compared to a conventional antibiotic,
norfloxacin for the development of resistance against
MRSA
.
With brilacidin, no bacterial resistance was seen in up to 40
serial passages